In order to determine the limits of physiological anemia in the African neonate, the hematological values of 402 healthy neonates were determined. It was observed that although the African neonate had much lower hematological values at birth when compared with their North American and European counterparts, the eventual nadir reached is approximately the same. The hematocrit, hemoglobin and red blood cell count of preterm infants on the first day of life were comparable to those of full-term and postterm infants. However, the preterm infants had a more precipitous drop in these values and, consequently, reached a nadir much lower than full-term and postterm infants. The nadir was reached between 6 and 8 weeks in each group. In all three groups, recovery was spontaneous and preceded by a rise in reticulocyte count. It is also significant that by 16 weeks of life, no significant difference exists between the values for preterm, full-term and postterm infants

Keywords:
African, Anemia, Hematology, Neonate, Reticulocytes
This content is only available via PDF.
© 1985 S. Karger AG, Basel
1985
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.